This observation was corroborated in analyzing TCGA breast cancer cohort DEG data, where a high hPRLrI:hPRLrL ratio associated with a greater likelihood of breast cancer brain relapse, distant metastasis, and KRAS activity. This evidence concerns the gene KRAS and breast carcinoma.